PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE II STUDY OF TIPIFARNIB IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA
Witzig, T., Sokol, L., Jacobsen, E., Advani, R., Mondejar, R., Piris, M., Burrows, F., Melvin, C., Mishra, V., Scholz, C., Gualberto, A.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_115
Date:
June, 2017
File:
PDF, 131 KB
english, 2017